FDA 483 - Rajinder S. Shiwach, M.D. - June 11, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Rajinder S. Shiwach, M.D. (Insite Clinical Research) in Desoto, TX, revealed significant deficiencies in clinical study conduct. Observations included failure to ensure proper IRB review and approval for a "guesting" process, as well as enrolling ineligible subjects and failing to discontinue treatment for subjects meeting discontinuation criteria. These findings indicate serious non-compliance with regulatory requirements for clinical investigations.
ID · bf794813-f214-49b3-a835-b8ffb75d0ee6